IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,748,397 | +26.6% | 258,308 | +25.2% | 0.01% | +11.1% |
| Q1 2023 | $2,170,360 | +2.9% | 206,308 | +21.1% | 0.01% | -18.2% |
| Q4 2022 | $2,109,943 | +52.6% | 170,294 | +27.5% | 0.01% | +37.5% |
| Q3 2022 | $1,383,000 | -18.4% | 133,531 | -9.2% | 0.01% | -38.5% |
| Q2 2022 | $1,695,000 | +140.1% | 147,025 | +161.9% | 0.01% | +116.7% |
| Q1 2022 | $706,000 | -61.4% | 56,140 | -64.2% | 0.01% | -57.1% |
| Q4 2021 | $1,828,000 | +104.2% | 156,795 | +128.9% | 0.01% | +27.3% |
| Q3 2021 | $895,000 | +13.0% | 68,501 | -1.5% | 0.01% | 0.0% |
| Q4 2020 | $792,000 | +40.9% | 69,532 | +27.6% | 0.01% | +37.5% |
| Q2 2020 | $562,000 | +244.8% | 54,505 | +236.6% | 0.01% | +14.3% |
| Q1 2020 | $163,000 | 0.0% | 16,194 | +32.1% | 0.01% | +40.0% |
| Q4 2019 | $163,000 | – | 12,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |